May 14, 2024Open Access

Trajectories of self-reported fatigue following initiation of multiple sclerosis disease-modifying therapy

Key Points

Key points are not available for this paper at this time.

Abstract

We analysed the COMparison Between All immunoTherapies for Multiple Sclerosis (NCT03193866), a Swedish nationwide observational study in relapsing-remitting multiple sclerosis (RRMS), to identify trajectories of fatigue and their association with physical disability following start of disease-modifying therapy (DMT).

Trajectories of self-reported fatigue following initiation of multiple sclerosis disease-modifying therapy

Key Points

Abstract

Cite This Study